$SNY and $GSK signed a letter of intent to collaborate on a #coronavirus vaccine. They expect the vaccine to enter clinical studies in the second half of 2020. If successful, it could be available in the second half of 2021. #pharmaceuticals #stocks #covid19 #investingnews